CONTACT US
While there continues to be an epidemic of opioid-related overdose deaths, many patients experience acute or chronic pain, making it crucial for clinicians to understand how to appropriately treat pain, while reducing opioid-associated risks. Not all clinicians are intimately familiar with the FDA’s Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS), which is essential in order to ensure that patients receive and understand the Medication Guides and information regarding the safe use of these products. This educational activity is highly relevant to interprofessional clinicians involved in the care of patients receiving opioid analgesic therapy, nonpharmacologic therapies, and non-opioid therapies for pain in hospitals, health systems and ambulatory care centers to appropriately manage pain and support the safe use of medication therapy for the treatment of pain.
Click Link to Register!
